Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2001
09/19/2001CN1313338A Polypeptide motif bound with human CD95 and its polypeptide
09/19/2001CN1313337A Polypeptide-zinc finger protein 10 and polynucleotide for coding it
09/19/2001CN1313336A Polypeptide-jhuman telomeric repetitive sequence bindin 14 and polynucleotide for coding it
09/19/2001CN1313335A Polypeptide-human uterin globin 40 and polynucleotide for coding it
09/19/2001CN1313334A Polypeptide-human sarcoma protein 67 and polynucleotide for coding it
09/19/2001CN1313333A Polypeptide-human NAD-depondent 2-hydroxy acid dehydrogenation family protein 16 and polynucleotide for coding it
09/19/2001CN1313332A Polypeptide-human NTF2 associated protein 16 and polynucleotide for coding it
09/19/2001CN1313331A Polypeptide-human plasminogen activator inhibitor 2-27 and polynucleotide for coding it
09/19/2001CN1313330A Polypeptide-human endothelial unicell activation polypeptide II-62 and polynucleotide for coding it
09/19/2001CN1313329A Polypeptide-human excitatory amino acid rotor 16 and polynucleotide for coding it
09/19/2001CN1313328A Polypeptide-human primary cadherin 14 and polynucleotide for coding it
09/19/2001CN1313327A Polypeptide-human junctional adhesion molecule 12 and polynucleotide for coding it
09/19/2001CN1313326A Polypeptide-human FD 11 and polynucleotide for coding it
09/19/2001CN1313325A Polypeptide-human zinc finger protein 15 and polynucleotide for coding it
09/19/2001CN1313324A Polypeptide-human hypoxia induction factor Lalpha subunit 13 and polynucleotide for coding it
09/19/2001CN1313323A Polypeptide-human amyloid glucoprotein 23 and polynucleotide for coding it
09/19/2001CN1313322A polypeptide human retinal tumor bindin 9 and polynucleotide for coding it
09/19/2001CN1313321A Polypeptide-human cannabinol receptor protein 7 and polynucleotide for coding it
09/19/2001CN1313320A Polypeptide-human cannabinol receptor protein 11 and polynucleotide for coding it
09/19/2001CN1313319A Polypeptide-human excitatory amino acid transporter 10 and polynucleotide for coding it
09/19/2001CN1313318A Human protein able to suppress growth of cancer cells and its coding sequence
09/19/2001CN1313317A Human protein able to suppress growth of cancer cells and its coding sequence
09/19/2001CN1313316A Human protein able to suppress growth of cancer cells and its coding squence
09/19/2001CN1313315A Human protein able to suppress growth of cancer cells and its coding sequence
09/19/2001CN1313314A Polypeptide-human signal recognition factor 12 and polynucleotide for coding it
09/19/2001CN1313313A Polypeptide-human CDC4 analogous protein 12 and polynucleotide for coding it
09/19/2001CN1313312A Polypeptide-human proteinase regulatory protein 10 and polynucleotide for coding it
09/19/2001CN1313311A Polypeptide-human NRG3-22 and polynucleotide for coding it
09/19/2001CN1313310A Polypeptide-human zinc finger protein 14 and polynucleotide for coding it
09/19/2001CN1313309A Polypeptide-human GAPa protein 9 and polynucleotide for coding it
09/19/2001CN1313307A Polypeptide-human Yiplp 28 and polynucleotide for coding it
09/19/2001CN1313306A Polypeptide-human HUMSTAH protein 9 and polynucleotide for coding it
09/19/2001CN1313305A Polypeptide-human guanine intertransform factor 17 and polynucleotide for coding it
09/19/2001CN1313304A Polypeptide-human TNFR/NGFR protein 9 of structural domain containing cytochrome and polynucleotide for coding it
09/19/2001CN1313303A Polypeptide-human nucleolar phospholation protein P130-17 and polynucleotide for coding it
09/19/2001CN1313302A Polypeptide-human zinc finger protein 27 and polynucleotide for coding it
09/19/2001CN1313301A Polypeptide-human thyrocalcitonin 15 and polynucleotide for coding it
09/19/2001CN1313300A Polypeptide-human interleukin conjugon 13 and polynucleotide for coding it
09/19/2001CN1313299A Polypeptide-human excitatory amino acid transporter 17 and polynucleotide for coding it
09/19/2001CN1313298A Human protein able to suppress growth of cancer cells and its coding sequence
09/19/2001CN1313297A Human protein able to suppress growth of cancer cells and its coding sequence
09/19/2001CN1313296A Polypeptide-zinc finger protein 62 and polynucleotide for coding it
09/19/2001CN1313295A Polypeptide-ZnT-1-22 and polynucleotide for coding it
09/19/2001CN1313294A Polypeptide-mTERF-42 and polynucleotide for coding it
09/19/2001CN1313293A Polypeptide-zinc finger protein 11 and polynucleotide for coding it
09/19/2001CN1313292A Polypeptide-amyloid precusor protein bindin 13 and polynucleotide for coding it
09/19/2001CN1313291A Polypeptide-ectodynamic protein arm Dhclalpha 47 and polynucleotide for coding it
09/19/2001CN1071378C Production of L-threonine by fermentation
09/19/2001CN1071336C Compositions by using unbound MPL receptor for stimulating platelet production
09/18/2001US6291745 Limonene and other downstream metabolites of geranyl pyrophosphate for insect control in plants
09/18/2001US6291744 A polynucleotide encoding an antimicrobial protein; tissue specific or constitutive promoters for producing transgenic plants that are herbicide or fungal disease resistant, bacterial resistant, improving ripening, color or sweetness
09/18/2001US6291743 Transgenic plants expressing mutant geminivirus AC1 or C1 genes
09/18/2001US6291742 Genetically engineering plants to produce seeds having a kappa hydroxylase construct integrated into its genome;increasing the amount of hydroxylated fatty acyl compound in the seeds
09/18/2001US6291741 Method for the production of modified plants
09/18/2001US6291740 Transgenic animals
09/18/2001US6291668 Oligonucleotide derivatives
09/18/2001US6291667 Method and composition for treatment of kaposi's sarcoma
09/18/2001US6291666 A genetically engineered construct; preventing scab disease caused by fusarium graminearum fungus in cereal grain plants; increase plant yields, disease resistance, extended shelf-life and enhance nutritional content
09/18/2001US6291664 Method of eliminating inhibitory/instability regions of mRNA
09/18/2001US6291663 TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
09/18/2001US6291662 A nucleic acid with serine protease inhibitor activity; therapy for emphysema, arthritis, glomerulonephritis, periodontial disease, muscular dystrophy, tumors, leukemia and sepsis
09/18/2001US6291661 flt3-L mutants and method of use
09/18/2001US6291659 A cdna present in fetal trophoblasts and adult circulating mono-nuclear cells; therapy for protecting the placenta from a maternal immune response (induction of immune tolerance)
09/18/2001US6291658 Isolated nucleic acid molecules encoding SSX family members and thereof
09/18/2001US6291654 Obtaining protein sample from bacteria, applying to solid support of methylamine treated complement protein c3, washing solid support, and removing c3 binding protein from solid support using alcohol solution
09/18/2001US6291650 Methods for producing members of specific binding pairs
09/18/2001US6291649 Anti-bodies binding adhesin-derived antigens
09/18/2001US6291647 Antifungal proteins, DNA coding therefor, and hosts incorporating same
09/18/2001US6291646 A receptor polypeptide having a ligand-binding domain joined to an immunoglobulin constant region; therapy for atherosclerosis, autocrine tumors, fibroplasia and keloid formation
09/18/2001US6291644 A protein; anticarcinogenic agents, apoptotic agents
09/18/2001US6291643 Apaf-1 an activator of caspase-3
09/18/2001US6291642 Mammalian cell cycle protein
09/18/2001US6291637 Peptide modulator of protein biosynthesis; for utilization as viricide
09/18/2001US6291516 Contacting the cell with a composition including at least one cyclic amp agonist.
09/18/2001US6291437 The protein/nucleic acid compositions are administered in an amount capable of inducing cell mediated immunity and/or antibody response in the subject.
09/18/2001US6291430 Mage-3 peptides presented by HLA class II molecules
09/18/2001US6291248 Isolating preferential nucleotide sequences in sample; incubate nucleotide sequences with silicon carbide and recover bound nucleotide sequences
09/18/2001US6291246 DNA virus vectors and methods for their preparation
09/18/2001US6291245 Host-vector system
09/18/2001US6291244 Method of producing transformed cells of barley
09/18/2001US6291243 Expression vectors for the insertion of genetic material into cells; for use in gene therapy
09/18/2001US6291242 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
09/18/2001US6291239 Immunoglobulin for the treatment and prevention of viral diseases
09/18/2001US6291238 Tranforming with expression vector of gene for yeast cytoplasmic pyruvate carboxylase and promoter for transcription control
09/18/2001US6291237 Cancer diagnosis and therapy based on mutations in TGF-β receptors
09/18/2001US6291236 Human cytomegalovirus DNA sequences
09/18/2001US6291227 Nucleotide sequences coding viral polypeptides; for use in the development of vaccines which prevent retroviral infections
09/18/2001US6291226 Adenovirus mutants with deleted protease gene
09/18/2001US6291225 Microorganismal material for use in the treatment, diagnosis and prevention of microorganismal infection
09/18/2001US6291224 Genes controlling phytate metabolism in plants and uses thereof
09/18/2001US6291219 Cancer diagnosis; genetic engineering; fucose transfer to n-acetylglucosamine
09/18/2001US6291218 Identification of eukaryotic growth-related genes and promoter isolation vector and method of use
09/18/2001US6291217 Glutathionylspermidine synthetase and processes for recovery and use thereof
09/18/2001US6291214 System for generating recombinant viruses
09/18/2001US6291213 Generating genetically engineered nucleotide sequences; incubate primers with nucleotide sequences, amplify sequences, denature products, incubate and amplify single-stranded products, recover amplified products
09/18/2001US6291212 Nucleotide sequences coding polypeptide for the detection and purification of human platelet derived growth factor or isoforms
09/18/2001US6291211 Expressing heterologous polypeptides in cells; incubate cells with expression vectors, transform cells, express heterologous polypeptide
09/18/2001US6291210 Differentiation inhibitor
09/18/2001US6291209 Genetically engineered aspergillus; for use in generation of heterolgous polypeptides
09/18/2001US6291208 Exprsssion vector; for use as diagnostic tools and generating vaccines